Sanofi sues Sarepta, alleging that Duchenne treatment Elevidys infringes on AAV patents

Sanofi is suing Sarepta Therapeutics, alleging that the company’s approved muscular dystrophy treatment infringes on its patents related to the chemical makeup of the product …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Chat GPT Plus doesn’t outperform conventional methods in diagnosing patients

With hospitals already deploying artificial intelligence to improve patient care, a new study has found that using Chat GPT Plus does not significantly improve the

November 14, 2024

Immunic to Participate in Scientific and Industry Conferences in November – Biotech Investments

Issuer: Immunic, Inc. / Key word(s): Conference 26.10.2023 / 12:30 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic to Participate

October 27, 2023

AstraZeneca on ‘independent’ manufacturing; Samsung Bio’s next ADC deal

Welcome to Endpoints News’ manufacturing news briefs, where we bring you essential updates on new builds, collaborations, recalls and more. AstraZeneca CEO Pascal Soriot said

February 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.